Hem-Onc News: Aspirin linked to cancer progression in older adults, inhibitor could 'alter landscape' of RET+ tumors, and Black-White gap closing
Blood & Cancer
English - September 01, 2020 08:00 - 14 minutes - 20.3 MB - ★★★★★ - 31 ratingsMedicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: SECURE-SCD: A registry of patients with sickle cell disease and COVID-19
MDedge Hematology-Oncology news for the first week of September 2020.
Aspirin may accelerate cancer progression in older adults: https://bit.ly/2ENHRUcASPREE trial: https://bit.ly/2QAsMYW
Meta-analysis: https://bit.ly/2D6rXnl
AsCaP: https://bit.ly/2G06X2I Black/White gap gone: ‘The only cancer where this has happened’: https://bit.ly/3jm8PBm
Source: https://bit.ly/3lv4u0m Selpercatinib 'poised to alter the landscape' of RET+ cancers: https://bit.ly/34PYSbs
Lung cancer results: https://bit.ly/3gB1FY7
Thyroid cancer results: https://bit.ly/2EHhCz5 Study confirms it's possible to get COVID-19 twice: https://bit.ly/3bd4wWg
Email the show: [email protected]
Learn more about MDedge and Blood & Cancer: https://www.mdedge.com/podcasts